Celera Q2 Revenues Soar; New Research Agreement Signed | GenomeWeb

NEW YORK, Jan 25 –- Celera said Thursday its second quarter fiscal 2001revenues surged to $20.3 million from $8.3 million in the year-ago period as the company continued to rack up one new commercial and three new academic subscribers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.